کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2408896 | 1103194 | 2007 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Previous studies with gonadotrophin releasing hormone (GnRH/LHRH) vaccines have shown the usefulness of immunization against this hormone in prostate cancer. To this end, we have generated a completely synthetic peptide modified at position 6 and attached to the 830–844 tetanic toxoid (TT) helper T cell sequence. Through this work we have demonstrated that the GnRHm1-TT molecule was highly immunogenic when it is formulated as an oil-based emulsion adjuvated with Montanide ISA 51. That results correlated directly with testosterone reduction and tumor growth inhibition of the Dunning R3327-H androgen responsive prostate tumor model in rats. GnRHm1-TT, proved to be safe and useful for future clinical trials.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 25, Issue 50, 5 December 2007, Pages 8460–8468
Journal: Vaccine - Volume 25, Issue 50, 5 December 2007, Pages 8460–8468
نویسندگان
Jesús A. Junco, Peter Peschke, Ivan Zuna, Volker Ehemann, Franklin Fuentes, Eddy Bover, Eulogio Pimentel, Roberto Basulto, Osvaldo Reyes, Lesvia Calzada, María D. Castro, Niurka Arteaga, Yovisleidis López, Hilda Garay, Héctor Hernández, Ricardo Bringas,